showing the working

← Oramed Pharmaceuticals

The business behind the dividend

MeasureORMPMedianFormula
Return on equity32.1%10.6%Net income ÷ shareholders’ equity
Return on capital employedOperating income ÷ (equity + total debt)
Owner earnings$64.16m$120.90mNet income + depreciation & amortisation − capital expenditure
Free cash flow$-9.15m$155.08mOperating cash flow − capital expenditure
Operating margin-754.4%14.3%Operating income ÷ revenue
Net marginNet income ÷ revenue
Debt to equityTotal debt ÷ shareholders’ equity
Interest coverOperating income ÷ interest expense
Current ratio6.98x1.55xCurrent assets ÷ current liabilities
Long-term debt to working capitalLong-term debt ÷ (current assets − current liabilities)
Cash conversion-0.14x1.66xOperating cash flow ÷ net income
Accruals31.7%-3.1%(Net income − operating cash flow) ÷ total assets

Not computed here: Debt to equity, Long-term debt to working capital, Interest cover, Return on capital employed — why a blank is not a zero.

Ten years of it

The same measures, for every year the filings support. One year is a fact; a row is a business.

Measure2025202420232022202120202019201820172016Median
Return on equity32.1%-13.0%3.1%-24.1%-19.9%-35.0%-74.0%-40.9%-54.5%-41.9%-35.0%
Return on capital employed-26.7%-50.4%-31.8%-31.8%
Operating margin-754.4%-896.2%-433.8%-541.3%-552.3%-438.6%-552.3%
Net margin-850.5%-424.8%-531.1%-519.7%-426.7%-519.7%
Debt to equity0.00x0.50x0.37x0.37x
Current ratio6.98x25.19x3.06x27.34x14.27x8.93x6.28x6.82x3.93x8.62x6.98x
Cash conversion-0.14x-2.02x-2.02x